跳至主要内容
临床试验/NCT04315909
NCT04315909Unknown2 期

A Randomized, Double-Blind, Parallel-group, Clinical Trial to Evaluate the Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers

Mashhad University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2019年8月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
24
试验地点
1
主要终点
Healing rate of the ulcer

研究概览

简要总结

The aim of this study is to evaluates the chance of non-healing Diabetic Foot Ulcers repair by reducing oxidative stress caused by diabetes by taking vitamin E and C supplements along with the use of Platelet-Rich Plasma-Fibrin Glue as an effective treatment for wound healing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DFU is classified as Wagner 1 -2 on the Wagner classification system.
  • Persons with type 1 or type 2 diabetes with a non-healing ulcer of at least 4 weeks duration.
  • If more than one non-healing wound is present, the largest of the wounds that is classified as a Wagner 1-
  • The index ulcer had to be clinically non-infected.
  • Ankle Brachial Index (ABI) greater than or equal to 0.
  • HemoglobinA1C (HbA1c) < 12
  • Index foot ulcer located on the plantar, medial, or lateral aspect of the foot (including all toe surfaces).
  • Wound area (length x width) measurement between 2 cm2 and 20 cm
  • Non-use of drugs that may interfere with wound healing, such as corticosteroids, immunosuppressive agents, and cytotoxic agents.
  • No smoking, alcohol or drug addiction.
  • Approved, informed, signed consent.

排除标准

  • Previous consumption of vitamin E and C supplements.
  • Index ulcer has exposed tendons, ligaments, muscle, or bone.
  • Confirmed presence of osteomyelitis, or if osteomyelitis is suspected.
  • Patients with renal deficiency, hepatic failure, has known immune insufficiency and cancer.
  • Subject is pregnant or plans to become pregnant during the duration of the trial.
  • Patient's blood vessels are non-compressible for ABI testing.
  • Patient is known to have a psychological, developmental, physical, emotional disorders.
  • Received systemic corticosteroids or immunosuppressive agents.

研究组 & 干预措施

Intervention group

Experimental

Patients with non-healing Diabetic Foot Ulcers treated with PRP-Fibrin-Glue plus vitamin supplements (E (200 IU/ 2day) and C (250 mg/ 2day) ) for 8 weeks.

干预措施: PRP-Fibrin Glue (Drug)

Intervention group

Experimental

Patients with non-healing Diabetic Foot Ulcers treated with PRP-Fibrin-Glue plus vitamin supplements (E (200 IU/ 2day) and C (250 mg/ 2day) ) for 8 weeks.

干预措施: Vitamin E and C (Dietary Supplement)

Control group

Experimental

Patients with non-healing Diabetic Foot Ulcers treated with PRP-Fibrin-Glue plus placebo for 8 weeks.

干预措施: PRP-Fibrin Glue (Drug)

Control group

Experimental

Patients with non-healing Diabetic Foot Ulcers treated with PRP-Fibrin-Glue plus placebo for 8 weeks.

干预措施: Placebo (Other)

结局指标

主要结局

Healing rate of the ulcer

时间窗: 2 months

Examination by a vascular surgery physician and documentation

Wound Size

时间窗: 2 months

Wound size will be measured with ruler for length, width as well as with digital imaging. Wound size will be assessed in digital images taken of the wound.

次要结局

  • Serum ESR at baseline and after the intervention(2 months)
  • Serum hs-CRP at baseline and after the intervention(2 months)
  • HbA1c at baseline and after the intervention(2 months)
  • Serum Urea at baseline and after the intervention(2 months)
  • Serum total bilirubin at baseline and after the intervention(2 months)
  • Serum Uric acid at baseline and after the intervention(2 months)
  • FBS at baseline and after the intervention(2 months)
  • Lipid Profile at baseline and after the intervention(2 months)
  • Serum Creatinine at baseline and after the intervention(2 months)
  • Serum Homocysteine at baseline and after the intervention(2 months)
  • Pro-Oxidant Antioxidant Balance at baseline and after the intervention(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daryoush Hamidi Alamdari

Associate professor

Mashhad University of Medical Sciences

研究点 (1)

Loading locations...

相似试验

The Effect of Platelet-Rich Plasma-Fibrin Glue in... | 临床试验